À¯·´ÀǾàǰû(European Medicines Agency, EMEA)ÀÇ ¾à¹°»ç¿ëÀÚ¹®À§¿øȸ(Committee for Medicinal Products for Human Use, CHMP)°¡ ¼¼°¡Áö ¾à¹°À» Çϳª·Î ÇÕÄ£ GSK»çÀÇ ÈíÀÔÁ¦ 'Innoviva' ´ëÇØ ±àÁ¤ÀûÀÎ ÀÇ°ßÀ» ¹ßÇ¥Çß´Ù.
15ÀÏ(ÇöÁö½Ã°¢) ·ÎÀÌÅÍ Åë½ÅÀº À¯·´ÀǾàǰûÀÇ ¹ßÇ¥¸¦ Àοë, ÀÌ°°ÀÌ º¸µµÇß´Ù.
Innoviva´Â fluticasone furoate, umeclidinium, vilanterol ÀÌ·¸°Ô 3°¡Áö ¾à¹°ÀÌ ÇÕÃÄÁø ÈíÀÔÁ¦·Î, ÇÏ·ç Çѹø »ç¿ëÇϸç, ÁßÁõ ¸¸¼º Æó¼â¼ºÆóÁúȯ ȯÀÚµéÀÇ ±âµµ¸¦ ¿©´Â µ¥ µµ¿òÀÌ µÇ´Â 3°¡Áö ´Ù¸¥ ¸ÅÄ¿´ÏÁòÀ» »ç¿ëÇϵµ·Ï ¸¸µé¾îÁø ¾à¹°ÀÌ´Ù.
GSK»ç´Â ¾à¹°»ç¿ëÀÚ¹®À§¿øȸ·ÎºÎÅÍ Innoviva ½ÂÀο¡ ´ëÇÑ ±àÁ¤ÀûÀÎ ÀÇ°ßÀ» ¹Þ¾Ò´Ù°í ¹àÇû´Ù.
¾à¹°»ç¿ëÀÚ¹®À§¿øȸ·ÎºÎÅÍ ±àÁ¤ÀûÀÎ ÀÇ°ßÀ» ¹Þ´Â °ÍÀº À¯·´¿¬ÇÕ ÁýÇàÀ§¿øȸ(European Commission)À¸·ÎºÎÅÍ ÆǸŠ½ÂÀÎÀ» ¾ò±â ÀüÀÇ ÃÖÁ¾ °ü¹® Áß Çϳª´Ù. À¯·´ ÁýÇàÀ§¿øȸÀÇ ÃÖÁ¾ °áÁ¤Àº 2017³â ¸»¿¡ ³ª¿Ã ¿¹Á¤ÀÌ´Ù.